Ocrevus 300 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FJT26
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $96,154
Award facts
- Contract value 100% obligated
- $96,154.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $96,154.24 to AmerisourceBergen Drug Corp for the supply of Ocrevus (ocrelizumab) 300 mg/10 mL vials. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. Ocrevus is a monoclonal antibody therapeutic used to treat multiple sclerosis, representing the specialized pharmaceutical products that AmerisourceBergen routinely supplies through federal medical procurement channels.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive pharmaceutical supply vehicle enabling the company to furnish a broad range of medications, vaccines, and medical supplies to support military healthcare systems globally. The contract vehicle reflects DLA's approach to medical supply chain management by establishing long-term relationships with capable prime vendors who can reliably deliver specialized pharmaceuticals to the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FJT26?
SPE2DB25FJT26 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FJT26 worth?
The government has obligated $96,154 on SPE2DB25FJT26.
Is contract SPE2DB25FJT26 an order under another contract?
Yes. SPE2DB25FJT26 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJT26 competed?
The extent of competition for SPE2DB25FJT26 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award